Please assess the completion status of the following clinical trial:

Trial Title: Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with inoperable pancreatic cancer (ICD-10 C25.0-3) at the Department of Surgical Gastroenterology of Haukeland University Hospital, who have volunteered to participate~Exclusion Criteria:~* Patient participated in an investigational study within 30 days prior to study entry (or, if longer, within five half-lives of the last dose of any investigational drug).~* Patient has severe chronic obstructive pulmonary disease or severe chronic asthma.~* Patient has a history of cardiovascular ischemia, acute myocardial infarction or unstable angina within 3 months prior to study entry.~* Patient has a history of any psychiatric disorder or cognitive impairment that would interfere with participation in the study.~* Patient has a known history of Hepatitis B, Hepatitis C or HIV infection.~* Patient requires dialysis or has severely impaired renal function, defined as a serum creatinine \> 180 mmol/L at the Screening Visit.~* Patient has severe impairment of liver function, defined as a serum albumin level ≤ 25 g/L and/or a Protrombin Time INR \> 2.3 (or APTT \> 6 seconds above the upper limit of normal) at the Screening Visit.~* Patient is pregnant or is breast-feeding.~* Patient is allergic to or intolerant of gemcitabine~* Patient is allergic to or intolerant of SonoVue® BRACCO ultrasound contrast agent~* Any reason why, in the opinion of the investigator, the patient should not participate.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Contrast-enhanced ultrasound (CEUS) (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).